| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steven Leonard Chapman | CEO AND PRESIDENT | 2025-12-01 | 1,394 | $237.05 | $330.44kSell |
| Steven Leonard Chapman | CEO AND PRESIDENT | 2025-12-01 | 2,050 | $238.13 | $488.16kSell |
| Steven Leonard Chapman | CEO AND PRESIDENT | 2025-12-01 | 956 | $239.44 | $228.90kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-12-01 | 474 | $239.53 | $113.54kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-12-01 | 1,527 | $238.24 | $363.80kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-12-01 | 250 | $237.77 | $59.44kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-12-01 | 749 | $237.23 | $177.68kSell |
| Roelof Botha | Director | 2025-11-24 | 15,336 | $237.69 | $3.65MSell |
| Roelof Botha | Director | 2025-11-24 | 2,000 | $228.97 | $457.93kSell |
| Roelof Botha | Director | 2025-11-24 | 1,000 | $230.03 | $230.03kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.98% | 12,389,033 | $2.95B | Institution |
| Price T Rowe Associates Inc | 8.66% | 11,947,415 | $2.85B | Institution |
| Jpmorgan Chase Co | 8.43% | 11,628,914 | $2.77B | Institution |
| Blackrock Inc | 7.94% | 10,964,351 | $2.61B | Institution |
| Claremont Creek Ventures L P | 4.25% | 5,864,630 | $1.40B | Insider |
| Roelof Botha | 4.06% | 5,609,069 | $1.34B | Insider |
| Sc XII Management LLC | 3.93% | 5,421,122 | $1.29B | Insider |
| Matthew Rabinowitz | 3.48% | 4,809,420 | $1.15B | Insider |
| James Healy | 3.40% | 4,697,100 | $1.12B | Insider |
| Farallon Capital Management LLC | 3.08% | 4,253,452 | $1.01B | Institution |